DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Harrison CN, Mead AJ, Panchal A. et al.
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
Blood 2017;
130 (17) 1889-1897
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.